Q&A with Latane Conant, CMO at 6sense

MEDIA 7 | July 17, 2019

Q&A with Latane Conant
Latane Conant, CMO at 6sense has always been keenly focused on leveraging data to ensure marketing programs result in deals, not just leads.

At 6sense, Latane helps sales and marketing leaders increase revenue by tapping into the power of predictive intelligence to uncover buyers who are ready to buy.

MEDIA 7: As a child, what did you want to be when you grew up?
LATANE CONANT:
The first thing I ever wanted to be was a lifeguard and swim coach. When I was 5 years old, I joined the swim team as one of the youngest swimmers. At 13, I was too young to be a lifeguard so I begged them to create a “JR lifeguard” position. This was essentially deck swabbing and towel service but I didn’t care. So they hired me and called me “young jedi”. The head lifeguard loved to play jokes on me. One time he gave me a ruler and said every deck chair needed to be 10 ¾ inches apart. There were 50+ deck chairs, but I went out and started measuring. Finally, after a few chairs, they called me over the loudspeaker to come back to the office and we all had a big laugh. Another time they took me down to the filter room, which was underground and pretty spooky.

BUT as a young jedi, I had to learn how the system worked. We descended under the deck and I climbed a rickety old ladder to look down into the pump. Another lifeguard in scuba gear was waiting underwater and jumped out of the filter tank and scared the bejesus out of me! Once I calmed down I thought it was pretty hysterical! My role could have been seen as pretty mundane - bathroom cleaning and towel folding - BUT I loved the people I worked with so much. I worshipped the lifeguards and swim coaches!

They kept me on my toes and in stitches all summer, so it’s still one of the best jobs I’ve ever had. I finally graduated to teaching swim lessons, with a focus on kids who did not swim at all and were afraid to go in the pool. Nothing was more rewarding than seeing someone do something they thought they could not, or actually loving something that used to scare them - like put their head underwater, dive off the blocks, or swim the butterfly stroke for a lap.

M7: Latane, you have always thrived on working with wicked smart people. How do you get the best out of them when there is a common notion that it’s difficult to make smart people work together?
LC: 
Talented people want to be able to do great work. Not the average, crank some blogs out or run an event, but truly cool and differentiated things. My job is to be a force field and ensure the team has the opportunity to try different things and do their best work. This means providing focus. A powerful focus tool we use is the V2MOM. V2MOM stands for Vision, Values, Methods, Obstacles, and Metrics. Vision is what you want to achieve. Ideally your vision makes everyone uncomfortably excited. Values are why it matters, what you believe, guiding principles for decision making. Methods are where the rubber meets the road and are the top things you will do to achieve the vision.

Under each method, it's key to detail out obstacles (so you can plan around them) and metrics so you know if the method is on track. What’s nice about the system is that it provides built-in planning and is time bound. So every quarter I get my team together and we revise our V2MOM. This builds consensus around the vision and how we are going to get there. Every method gets assigned an owner, which drives accountability. And we publically track the metrics weekly so everyone knows our progress. The interesting thing about the V2MOM is not what's on the V2mom but what is NOT on the V2MOM. Because the process requires hyper prioritization of what you are going to do in a given time period, it forces focus.

I’m pretty obsessed and love the V2MOM. I am happy to share more on how teams can adopt, implement, and use it.  In fact, maybe in my next life, I will be a V2mom consultant!


"Marketing is harder and harder these days because buyers want to remain anonymous."

M7: How does leveraging smart technologies like AI help marketers have an edge over others and achieve on-time targets?
LC:
We need every advantage we can get in order to be successful and AI provides that advantage. Marketing is harder and harder these days because buyers want to remain anonymous. In fact, 90 percent of B2B buying behavior is digital and anonymous. Buyers also buy in teams, so the buying journey and process is very fragmented across many people. According to Gartner, it’s typical for a buying team to have more than 10 people involved. Adding to that, buyers are resistant. Every member of the B2B buying team requires highly personalized multi-touch and multi-channel engagement to take a meeting.
But our current systems are built for known static data, which only 12% of marketers have confidence in.
Revenue-generating teams should look for platforms that allow them to uncover buyer behavior, particularly the anonymous behavior, so they can stop spending money, time, and energy on the accounts that aren’t even in-market. Instead, through AI and big data, that money, time and energy can be used to uncover their “dark funnel,” or the rich information that is being done on your company and/or solution in the dark. Next, they must prioritize. Look across behavior to determine and group buying teams. Look for changes in behavior over time to fully grasp which accounts are in-market, ready for an upsell, or have potential to churn. AI can deliver these insights with a high degree of accuracy so you can know when accounts are getting ready to open opportunities. Enabling you to focus your time, salespeople and BDRs on the BEST accounts. Once you have uncovered anonymous behavior and prioritized timing, it’s time to engage. Engaging is about orchestrating multi-touch, multi-channel, highly personalized messages at scale. This is where AI really shines. It tells us the best time to use display ads vs. email vs a direct mailer and even triggers actions across channels. It also ensures we are personalizing appropriately so if someone has consumed the demo it offers them another piece of content so they aren’t served the demo AGAIN.  Based on their behavior, buying stage, persona, and company we can dynamically deliver the best experience. Teams that use this approach see unbelievable results and are beating out their competition with 40 percent more opportunities, 5x larger deals, and 1.5x faster cycle times.


"Engaging is about orchestrating multi-touch, multi-channel, highly personalized messages at scale. This is where AI really shines."

M7: How does 6sense’s Account Based Orchestration Platform help revenue teams to compete and win in the age of account-based buying?
LC:
I had my team do some research on the typical results b2b sales and marketing teams see from their efforts. The picture is not pretty. In fact EVERY minute:
- DOZENS of interested buyers will visit your website but only ONE will identify themselves.
- Your most important prospect will receive 2 NEW EMAILS. They will likely delete them both without opening.
- Your sales reps will spend ONE-QUARTER of their time on leads who have no intention to buy.
- Your BDR team will make just over 6 calls. They will book ZERO meetings.

No wonder marketing and sales teams get misaligned. This is not competing or winning.

Account Based Marketing is all the rage - It requires selecting the best accounts to go after, detailed insights into accounts and personas, highly personalized multi-channel engagement, alignment with sales, and the ability to track “real stuff” like increased engagement, pipeline, and revenue. ABM makes a lot of sense vs. traditional tactics that result in millions of unopened emails that get sent each year, thousands of dollars spent on swag at events that don’t lead to an opportunity, etc. However, the dirty little secret is that it’s impossible to scale without GREAT customer insights and orchestration capabilities. This is why you hear a lot about ABM pilots and not about ABM at scale.
6sense brings sales, business development, customer success, and marketing together on one platform that provides an unprecedented level of insights and the ability to take action. 

6sense delivers ABM at scale by providing (at a click in an easy to use UI):
- an understanding of best accounts to go after based on your business objective, technographic, firmographic, and real-time behavioral information.
- insights into the key personas to engage, the topics they care about, and where they are in their buying stage.
- orchestrated engagement across tactics from email, to display ads, to direct mail.
- alerts for sales with relevant details like when to call, what to say, what accounts are doing anonymously/in the “dark funnel”, and what marketing activities are working.
- tracking and metrics around how campaigns perform, if new personas engage, if you influenced opportunities, and if you gained net new opportunities.

This means sales and marketing can get BACK to sales and marketing, aligning on a business objective, messaging, and the experience you want to deliver for prospects - one you can actually be proud of. One without useless forms, spam, and cold calls. And because our platform provides transparency, reduced mundane work, and competitive advantage, prospecting actually becomes fun!

M7: What is the “dark funnel” and how can marketers embrace that?
LC:
So, the dark funnel is all of the data, information, people, and research that is happening right now for our product or solution that we have no insights into. You have to zoom out and think about the complexity of this cycle and how it’s changed. First of all, B2B buyers want to remain anonymous for as long as possible and our trick to making them not anonymous was to have some sort of gated content or to maybe try to run them down at a trade show or scan them but that doesn’t work anymore. All of our systems are set up for contact or a lead which is one person. What we find now is buyers buying in these teams, so you have to be able to understand how one person on the team is interacting with another person, how to put them together and how their collective research and desires come together. And again, all of that’s happening anonymously. So, the dark funnel research just went from one person to ten peoples’ research.

The other challenge is, in order to engage with buyers because they get so much noise and are so inundated, in fact in B2B we send about 300 billion emails a year, there’s only 7.7 billion people in the world and that’s not even B2C, so that doesn’t mean they’re on pottery barn’s list. So, our email motion in being able to break out of the noise is incredibly difficult. Hence, we have to have more touches and more capabilities and all of those emails and things that we’re sending are all in this dark funnel, we don’t truly understand how they’re getting consumed. So what ends up happening is we as marketers have to do a lot of guessing in how we design our programs and how we engage with customers and when you can start to really shine a light on the dark funnel and understand that rich research and the buying team and most importantly understand where they are in their journey, understand the timing. Rather than spamming you can start to really personalize in engagement and experience based on what they care about, who they are and most importantly, where they are in the buying journey.


"6sense brings sales, business development, customer success, and marketing together on one platform that provides an unprecedented level of insights and the ability to take action."

M7: To what extent does having a deep insight into a prospect’s buying journey help marketers in sales conversion and closing deals?
LC: 
Marketing is hard, selling is harder, and being a business development rep is the HARDEST. Business Development Reps and AE’s are expected to make hundreds of calls and send tons of email a week, but how do they know the contacts they are calling on aren’t random? Are they even in-market? How do they know when the best time to call is or what to even discuss without knowing the contacts needs? With outbound efforts, BDR’s and AE’s want opportunities, not just activity, but they don’t have a good way to make the right connections with the right content in order to be successful.

To reduce turnover and give outbound sales teams the best chance of success, we have to give them insights, with a robust group of digital signals to show if an account is actually in-market to buy or beginning the early stages of research. And with potential buyers leaving a digital footprint in the form of intent signals across the internet, both known and anonymous interactions with your website, as well as thousands of other 3rd party sites, we can take the guesswork out of identifying which accounts to target and what topics or competitors those accounts are searching.

Deep insights from 6sense help marketing, sales, and BDRs understand where each account is in their buyer journey and focus efforts on those who are actively in-market or in the early stages of research for our product or service. This lets the sales team know the ideal time to engage and what the account is interested in, taking the conversation from a cold call to a productive, meaningful one, driving higher conversions, win rates, and average deal size.

M7: 6sense recently launched Account-Based External Media Campaigns Analytics. How is it enabling media campaign effectiveness?
LC: 
The days of a four martini lunch and a deal are long gone since buyers don't want to talk to sales until they are 70% through the journey. Because of this shift, B2B digital ad spend is projected to hit $6.08 billion this year. It is an effective way to reach buyers in target accounts if done strategically with insights and proper measurement.

This feature focuses on digital agencies and the brands they work with. They use 6sense and all the rich insights on behavior and keywords in their campaign planning. It enables them to micro-segment and take an audience first approach vs designing a campaign and then finding an audience, flipping the campaign planning process on its head. 6sense also allows agencies to compare campaigns across different channels - tracking reach, engagement, and influence of these campaigns on accounts they are targeting for their customers.
Innovative agencies are partnering with us to deliver for their customers and they are seeing high returns on their investment.

M7: What is your favorite quote?
LC: 
“Anything worth doing is worth overdoing.” - Mick Jagger

ABOUT 6SENSE

6sense’s Account Based Orchestration Platform helps revenue teams compete and win in the age of Account Based Buying by putting the power of AI, big data and machine learning behind every member of the B2B revenue team, empowering them to uncover anonymous buying behavior, prioritize fragmented data to focus on accounts in market, and engage resistant buying teams with personalized, omni-channel, multi-touch campaigns. 6sense helps revenue teams know everything they need to know about their buyers so they can easily do anything they need to do to generate more opportunities, increase deal size, get into opportunities sooner, compete and win more often.

More C-Suite on deck

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Paula Muto, Founder and CEO of UBERDOC Inc.

September 6, 2021

Paula Muto, M.D., F.A.C.S., Founder and CEO of UBERDOC, is also the Director of the Vein Center at Mutosurgical. A graduate of Amherst College and New York Medical College, Dr. Muto is a fellowship-trained vascular surgeon by specialty who also practices general surgery. Paula is an advocate of disruption in healthcare and speaks passionately on many issues regarding transparency in healthcare, patient rights, and ensuring patient access to the care they need and deserve.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Paula Muto, Founder and CEO of UBERDOC Inc.

September 6, 2021

Paula Muto, M.D., F.A.C.S., Founder and CEO of UBERDOC, is also the Director of the Vein Center at Mutosurgical. A graduate of Amherst College and New York Medical College, Dr. Muto is a fellowship-trained vascular surgeon by specialty who also practices general surgery. Paula is an advocate of disruption in healthcare and speaks passionately on many issues regarding transparency in healthcare, patient rights, and ensuring patient access to the care they need and deserve.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Related News

HEALTHCARE ANALYTICS

Tomorrow Health Cements its Focus as the Premier Partner for Home-based Care Providers by Closing its Medical Supply Business

PRNewswire | May 29, 2023

Tomorrow Health, an innovator in home-based care, announced that it has closed its first-party home medical equipment (HME) supply business to remove barriers and unlock new opportunities for its network of home-based care providers. Tomorrow Health serves as a partner for home-based care needs to leading suppliers, including AdaptHealth, Apria, Home Care Delivered, Lincare, and Rotech Healthcare, providing each with holistic technology solutions that streamlines end-to-end workflows and enables unparalleled operational efficiency at scale. Tomorrow Health's vision has always been to restore the home as the primary point of care. Initially, it sought to achieve this vision by operating its own home medical equipment (HME) supplier business. A more powerful opportunity to shift care to the home quickly revealed itself: the transformation of the end-to-end process of how HME is ordered, processed, and delivered to patients at scale. Tomorrow Health evolved, building a market-leading connective technology and service layer that coordinates care seamlessly across payers, referring providers, patients and home-based care suppliers. The company's unique approach, built on its prior learnings as an HME supplier business, has delivered technology that supercharges home-based care provider growth via high-quality, cost-effective care. With its technology seeing rapid adoption and impact, Tomorrow Health has formally closed its HME supplier business. Tomorrow Health's decision to concentrate its focus on technology for supplier partners comes as the broader healthcare ecosystem shifts its strategic priorities and seeks greater support in enabling the delivery and reimbursement of quality home-based care. Nearly 91% of health plans have recently indicated plans to move more care to the home. HME suppliers are facing a critical challenge: meeting that demand in an operationally efficient manner. A recent HME delivery cost survey found that new personal protective equipment expenses, plus longer round trips with associated fuel and labor expenses, have increased overall delivery costs by 30% or more for most suppliers. "HME suppliers are a critical lever to shift care to the home, which is often overlooked by payors," Vijay Kedar, CEO and Co-Founder, Tomorrow Health." Tomorrow Health's technology and unique position with payors enables change end-to-end, supporting everything from prescription to reimbursement while arming suppliers with valuable insights that can drive business growth and ensure positive experiences for every single stakeholder." "Tomorrow Health is not only focused on delivering high-quality, innovative technology to suppliers in need of operational efficiencies, but they're also connecting with suppliers to understand what is and isn't working for them," said Tom Ryan, President and CEO, American Association for Homecare (AAHomecare), an advocacy organization for home-care providers and DME and HME companies. "By actively seeking out and listening to feedback from the supplier community, Tomorrow Health has been able to build a solution that drives definitively better outcomes for everyone." Many suppliers today receive HME orders from one-size-fits-all digital solutions that don't meet payor requirements or specific clinical needs. Tomorrow Health delivers an intuitive, precise digital order to suppliers within its platform, prioritizing urgent, same-day orders and queuing other provider orders as they come in, in compliance with payor requirements. Tomorrow Health has reduced supplier operating expenses by up to 24%. All necessary documentation is included in the order, with 87% of orders having enough information to be immediately serviceable. The supplier also has the ability to communicate with all necessary parties, including payers and providers, about the order through the platform. "Our partnership with Tomorrow Health enables us to automate and dramatically scale Home Care Delivered's best-in-class customer onboarding process, while simultaneously allowing us to drive the clinical, quality, and financial outcomes that are needed by patients, their healthcare providers, and payers," said Lowell Price, Senior Vice President of Business Development and Chief Growth Officer of Home Care Delivered. "While there are other e-platforms in the market today that we support, none are more strategically aligned to us in both commitment and capability to delivering value-based care in DME than Tomorrow Health. We couldn't be more excited about our partnership." About Tomorrow Health Tomorrow Health builds technology that improves the way home-based care is ordered, delivered, and paid for. Today, the home-based care ecosystem is fragmented, confusing, and expensive, costing the healthcare system billions of dollars annually. Tomorrow Health manages and improves every step of the process, using technology-driven matching and considering quality, specialization, insurance coverage, and geography to pair patients with appropriate suppliers of more than 40,000 products and services, leading to improved patient health results and lowered costs. Tomorrow Health partners with more than 125 leading health plans and health systems nationwide, including Pennsylvania's Geisinger Health Plan, and is backed by Andreessen Horowitz, BOND, Obvious Ventures, BoxGroup, Rainfall Ventures, and Sound Ventures.

Read More

MEDICAL DEVICES

IntakeQ Debuts Medical E-Prescribing Within its PracticeQ Platform for U.S. Healthcare Professionals

Businesswire | June 02, 2023

IntakeQ and its PracticeQ practice management system, which includes best-in-class customizable intake forms and software for healthcare, today announced the launch of electronic medical prescribing (e-prescribing) within its PracticeQ platform for clinicians in the United States. The new feature is made possible through a direct integration with ScriptSure Cloud ERX (ScriptSure) on the Surescripts platform. “Integrated solutions like e-prescribing help providers save time by enabling them to remain on a single familiar platform,” said Keith Pirkle, general manager of IntakeQ. “Our primary goal is to create a secure, integrated and affordable platform that any allied health or medical professional can use to help their practice succeed. This collaboration with an esteemed partner like ScriptSure affirms our commitment to elevating the standard of care through technology. Ultimately, alongside the clinicians we serve, we are elated to enable this integrated and enhanced capability that will do what matters most: deliver a seamless patient experience.” Integrated prescribing provides several benefits including Improved patient safety with a reduction in prescription errors and checks for medication interactions Elimination of CMS e-prescribing penalties Formulary compliance and reduced costs for patients Single-click access to First Databank (FDB) and Prescriber’s Digital Reference (PDR) drug information Saved time through direct integration in PracticeQ Validated and error-free prescriptions, including controlled substances Pirkle added, “Our customers help drive the direction of IntakeQ and PracticeQ’s continued evolution in relation to technology and partnerships. We never see our software as complete in an ever-changing healthcare landscape. Listening to our customers, advisory board and our employees is our north star and our inspiration for continued development and innovation.” ScriptSure Cloud ERX is a 10-time winner of the Surescripts network White Coat Award, and most recently, the recipient of the 2022 Surescripts White Coat Award™ for highest accuracy of prescription transactions. About PracticeTek PracticeTek is an alliance of innovative software solutions that deliver exceptional patient experiences, attract new patients, and make the business of healthcare easier for clinicians.

Read More

HEALTH TECHNOLOGY

Apollo Launches Next-Generation Platform for Rapid Insights in Healthcare and Life Sciences

Businesswire | June 01, 2023

Apollo Intelligence (Apollo), a leading provider of real-time global data and insights to the healthcare and life science industries, announces the launch of its next-generation market insights technology platform to support rapid insights and data collection in the healthcare and life science industries. The advanced platform is fueled by the company’s ongoing investments in its core technologies, propelled by machine learning (ML) and artificial intelligence (AI). With a modern enterprise data architecture, built from best-in-class technologies, Apollo’s next-generation platform provides customers with advanced capabilities to support their progressive insight and data needs. The platform uses ML sampling intelligence to reach global healthcare professional (HCP) panelists with higher efficiency, offering the right research opportunities to the right HCP stakeholders, at the right place and time. This new, advanced capability fosters a seamless cycle of targeted interaction and ongoing engagement that enables greater speed-to-insight and higher quality data. For HCPs, Apollo’s enhanced routing capabilities mean they receive more relevant and matched opportunities to share their expertise and amplify their voice. Capabilities currently rolling out in beta include natural language processing (NLP) advancements in open text analysis for tagging, coding, ML-enhanced adverse event (AE) detection, and reporting. ML-based honoraria optimization for panel engagement. dynamic profiling and validation. In the second half of 2023, these foundational capabilities will support further ML and AI advancements focused on sentiment analysis for free text, survey automation, and expanded global capabilities. “Apollo has been on a multi-year, multimillion-dollar journey building towards this moment when our investments in data and technology would allow us to take advantage of advances in machine learning and data science applications to provide our clients with an unmatched service experience,” said Daniel S. Fitzgerald, president and CEO of Apollo Intelligence. “Life science companies will be able to see the immediate impact in speed and data quality as we leverage machine learning to intelligently sample our HCP communities for data collection. These advances are just the beginning for Apollo as we continue our innovative journey and extend our robust roadmap to deliver higher quality data, speed-to-insight, and advanced analytics and data visualization for our clients.” Apollo has made sizable investments in its platform since 2019 in anticipation of this launch. Its relationship with Frazier Healthcare Partners, in June 2022, has accelerated investment in these areas, with Frazier and Apollo sharing a vision for technological innovation within the healthcare data and insights market. The Frazier Data and AI Center of Excellence has been an instrumental partner in rapidly advancing these modern elements and realizing Apollo’s technology vision. Apollo Intelligence Apollo’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry. In 2020, Apollo strengthened its global reach by acquiring Survey Healthcare Global, a global market leader of first-party healthcare data collection and custom survey solutions. Apollo provides access to 2 million healthcare stakeholders worldwide—including physicians, patients, caregivers, and allied healthcare professionals. Apollo’s 250+ employees support top global pharmaceutical brands, market research agencies, and consultancies across 13 different countries in the Americas, Europe, and Asia. Apollo is a portfolio company of Frazier Healthcare Partners.

Read More

HEALTHCARE ANALYTICS

Tomorrow Health Cements its Focus as the Premier Partner for Home-based Care Providers by Closing its Medical Supply Business

PRNewswire | May 29, 2023

Tomorrow Health, an innovator in home-based care, announced that it has closed its first-party home medical equipment (HME) supply business to remove barriers and unlock new opportunities for its network of home-based care providers. Tomorrow Health serves as a partner for home-based care needs to leading suppliers, including AdaptHealth, Apria, Home Care Delivered, Lincare, and Rotech Healthcare, providing each with holistic technology solutions that streamlines end-to-end workflows and enables unparalleled operational efficiency at scale. Tomorrow Health's vision has always been to restore the home as the primary point of care. Initially, it sought to achieve this vision by operating its own home medical equipment (HME) supplier business. A more powerful opportunity to shift care to the home quickly revealed itself: the transformation of the end-to-end process of how HME is ordered, processed, and delivered to patients at scale. Tomorrow Health evolved, building a market-leading connective technology and service layer that coordinates care seamlessly across payers, referring providers, patients and home-based care suppliers. The company's unique approach, built on its prior learnings as an HME supplier business, has delivered technology that supercharges home-based care provider growth via high-quality, cost-effective care. With its technology seeing rapid adoption and impact, Tomorrow Health has formally closed its HME supplier business. Tomorrow Health's decision to concentrate its focus on technology for supplier partners comes as the broader healthcare ecosystem shifts its strategic priorities and seeks greater support in enabling the delivery and reimbursement of quality home-based care. Nearly 91% of health plans have recently indicated plans to move more care to the home. HME suppliers are facing a critical challenge: meeting that demand in an operationally efficient manner. A recent HME delivery cost survey found that new personal protective equipment expenses, plus longer round trips with associated fuel and labor expenses, have increased overall delivery costs by 30% or more for most suppliers. "HME suppliers are a critical lever to shift care to the home, which is often overlooked by payors," Vijay Kedar, CEO and Co-Founder, Tomorrow Health." Tomorrow Health's technology and unique position with payors enables change end-to-end, supporting everything from prescription to reimbursement while arming suppliers with valuable insights that can drive business growth and ensure positive experiences for every single stakeholder." "Tomorrow Health is not only focused on delivering high-quality, innovative technology to suppliers in need of operational efficiencies, but they're also connecting with suppliers to understand what is and isn't working for them," said Tom Ryan, President and CEO, American Association for Homecare (AAHomecare), an advocacy organization for home-care providers and DME and HME companies. "By actively seeking out and listening to feedback from the supplier community, Tomorrow Health has been able to build a solution that drives definitively better outcomes for everyone." Many suppliers today receive HME orders from one-size-fits-all digital solutions that don't meet payor requirements or specific clinical needs. Tomorrow Health delivers an intuitive, precise digital order to suppliers within its platform, prioritizing urgent, same-day orders and queuing other provider orders as they come in, in compliance with payor requirements. Tomorrow Health has reduced supplier operating expenses by up to 24%. All necessary documentation is included in the order, with 87% of orders having enough information to be immediately serviceable. The supplier also has the ability to communicate with all necessary parties, including payers and providers, about the order through the platform. "Our partnership with Tomorrow Health enables us to automate and dramatically scale Home Care Delivered's best-in-class customer onboarding process, while simultaneously allowing us to drive the clinical, quality, and financial outcomes that are needed by patients, their healthcare providers, and payers," said Lowell Price, Senior Vice President of Business Development and Chief Growth Officer of Home Care Delivered. "While there are other e-platforms in the market today that we support, none are more strategically aligned to us in both commitment and capability to delivering value-based care in DME than Tomorrow Health. We couldn't be more excited about our partnership." About Tomorrow Health Tomorrow Health builds technology that improves the way home-based care is ordered, delivered, and paid for. Today, the home-based care ecosystem is fragmented, confusing, and expensive, costing the healthcare system billions of dollars annually. Tomorrow Health manages and improves every step of the process, using technology-driven matching and considering quality, specialization, insurance coverage, and geography to pair patients with appropriate suppliers of more than 40,000 products and services, leading to improved patient health results and lowered costs. Tomorrow Health partners with more than 125 leading health plans and health systems nationwide, including Pennsylvania's Geisinger Health Plan, and is backed by Andreessen Horowitz, BOND, Obvious Ventures, BoxGroup, Rainfall Ventures, and Sound Ventures.

Read More

MEDICAL DEVICES

IntakeQ Debuts Medical E-Prescribing Within its PracticeQ Platform for U.S. Healthcare Professionals

Businesswire | June 02, 2023

IntakeQ and its PracticeQ practice management system, which includes best-in-class customizable intake forms and software for healthcare, today announced the launch of electronic medical prescribing (e-prescribing) within its PracticeQ platform for clinicians in the United States. The new feature is made possible through a direct integration with ScriptSure Cloud ERX (ScriptSure) on the Surescripts platform. “Integrated solutions like e-prescribing help providers save time by enabling them to remain on a single familiar platform,” said Keith Pirkle, general manager of IntakeQ. “Our primary goal is to create a secure, integrated and affordable platform that any allied health or medical professional can use to help their practice succeed. This collaboration with an esteemed partner like ScriptSure affirms our commitment to elevating the standard of care through technology. Ultimately, alongside the clinicians we serve, we are elated to enable this integrated and enhanced capability that will do what matters most: deliver a seamless patient experience.” Integrated prescribing provides several benefits including Improved patient safety with a reduction in prescription errors and checks for medication interactions Elimination of CMS e-prescribing penalties Formulary compliance and reduced costs for patients Single-click access to First Databank (FDB) and Prescriber’s Digital Reference (PDR) drug information Saved time through direct integration in PracticeQ Validated and error-free prescriptions, including controlled substances Pirkle added, “Our customers help drive the direction of IntakeQ and PracticeQ’s continued evolution in relation to technology and partnerships. We never see our software as complete in an ever-changing healthcare landscape. Listening to our customers, advisory board and our employees is our north star and our inspiration for continued development and innovation.” ScriptSure Cloud ERX is a 10-time winner of the Surescripts network White Coat Award, and most recently, the recipient of the 2022 Surescripts White Coat Award™ for highest accuracy of prescription transactions. About PracticeTek PracticeTek is an alliance of innovative software solutions that deliver exceptional patient experiences, attract new patients, and make the business of healthcare easier for clinicians.

Read More

HEALTH TECHNOLOGY

Apollo Launches Next-Generation Platform for Rapid Insights in Healthcare and Life Sciences

Businesswire | June 01, 2023

Apollo Intelligence (Apollo), a leading provider of real-time global data and insights to the healthcare and life science industries, announces the launch of its next-generation market insights technology platform to support rapid insights and data collection in the healthcare and life science industries. The advanced platform is fueled by the company’s ongoing investments in its core technologies, propelled by machine learning (ML) and artificial intelligence (AI). With a modern enterprise data architecture, built from best-in-class technologies, Apollo’s next-generation platform provides customers with advanced capabilities to support their progressive insight and data needs. The platform uses ML sampling intelligence to reach global healthcare professional (HCP) panelists with higher efficiency, offering the right research opportunities to the right HCP stakeholders, at the right place and time. This new, advanced capability fosters a seamless cycle of targeted interaction and ongoing engagement that enables greater speed-to-insight and higher quality data. For HCPs, Apollo’s enhanced routing capabilities mean they receive more relevant and matched opportunities to share their expertise and amplify their voice. Capabilities currently rolling out in beta include natural language processing (NLP) advancements in open text analysis for tagging, coding, ML-enhanced adverse event (AE) detection, and reporting. ML-based honoraria optimization for panel engagement. dynamic profiling and validation. In the second half of 2023, these foundational capabilities will support further ML and AI advancements focused on sentiment analysis for free text, survey automation, and expanded global capabilities. “Apollo has been on a multi-year, multimillion-dollar journey building towards this moment when our investments in data and technology would allow us to take advantage of advances in machine learning and data science applications to provide our clients with an unmatched service experience,” said Daniel S. Fitzgerald, president and CEO of Apollo Intelligence. “Life science companies will be able to see the immediate impact in speed and data quality as we leverage machine learning to intelligently sample our HCP communities for data collection. These advances are just the beginning for Apollo as we continue our innovative journey and extend our robust roadmap to deliver higher quality data, speed-to-insight, and advanced analytics and data visualization for our clients.” Apollo has made sizable investments in its platform since 2019 in anticipation of this launch. Its relationship with Frazier Healthcare Partners, in June 2022, has accelerated investment in these areas, with Frazier and Apollo sharing a vision for technological innovation within the healthcare data and insights market. The Frazier Data and AI Center of Excellence has been an instrumental partner in rapidly advancing these modern elements and realizing Apollo’s technology vision. Apollo Intelligence Apollo’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry. In 2020, Apollo strengthened its global reach by acquiring Survey Healthcare Global, a global market leader of first-party healthcare data collection and custom survey solutions. Apollo provides access to 2 million healthcare stakeholders worldwide—including physicians, patients, caregivers, and allied healthcare professionals. Apollo’s 250+ employees support top global pharmaceutical brands, market research agencies, and consultancies across 13 different countries in the Americas, Europe, and Asia. Apollo is a portfolio company of Frazier Healthcare Partners.

Read More

Spotlight

6sense

6sense

6sense’s Account Based Orchestration Platform helps revenue teams compete and win in the age of Account Based Buying by putting the power of AI, big data and machine learning behind every member of the B2B revenue team, empowering them to uncover anonymous buying behavior, prioritize fragmented data...

Events

Resources